能倍乐 思力华噻托溴铵怎么样

How is it?

Respimat Tiotropium is a long-acting anticholinergic drug with similar affinity for the five choline receptors (M1-M5). It dilates bronchial smooth muscle by binding to M3 receptors on smooth muscle. This effect is competitive and reversible. In vivo and in vitro studies have shown that Respimat, Slava, Tiotropium bromide has a dose-dependent and sustainable 24-hour inhibition of methacholine-induced bronchoconstriction. Respimat's bronchial dilation effect has outstanding localization selectivity.

The approval of Tiotropium bromide for Respimat and Slivar was based on data from two pivotal Phase III trials (TONADO-1, -2). The study involved more than 5,000 patients with COPD. The data showed that compared with placebo, tiotropium bromide and olodaterol monotherapy, Respimat, Slivar and tiotropium bromide resulted in a statistically significant improvement in patients' lung function (FEV1), and had a similar safety profile to tiotropium bromide or olodaterol.

Chronic obstructive pulmonary disease (COPD) is a chronic bronchitis and/or emphysema characterized by airflow obstruction, which can further develop into common chronic diseases such as cor pulmonale and respiratory failure. It is related to the abnormal inflammatory response of harmful gases and harmful particles, and has a high disability and mortality rate. The global incidence rate for people over 40 years old has been as high as 9% to 10%. Respimat, Tiotropium, and Tiotropium bromide are FDA-approved bronchodilators for the treatment of chronic obstructive pulmonary disease (COPD).

Respimat, Slivar Tiotropium has played an important role in the treatment of COPD since its launch. Respimat, Slivar Tiotropium has brought good clinical benefits to the maintenance treatment of chronic obstructive pulmonary diseases, including chronic bronchitis and emphysema, as well as the maintenance treatment of dyspnea and the prevention of acute exacerbations. It is a good choice for domestic patients.

Before receiving treatment, patients should go to the hospital for a detailed examination and strictly take medication according to the doctor's diagnosis and treatment recommendations. During the treatment period, patients should not increase or decrease the dosage of drugs without authorization. Only correct use of drugs will help the condition.